Coffee, CYP1A2 Genotype, and Risk of Myocardial Infarction

• Published in: JAMA : the journal of the American Medical Association 2006-03, Vol.295 (10), p.1135-1141
• Main Authors: Cornelis, Marilyn C, El-Sohemy, Ahmed, Kabagambe, Edmond K, Campos, Hannia
• Format: Article
• Language: English
• Subjects: Aged; Amino Acid Substitution; Biological and medical sciences; Caffeine; Cardiology. Vascular system; Catchment Area (Health); Coffee; Coffee - adverse effects; Coronary heart disease; Costa Rica; Cytochrome P-450 CYP1A2 - genetics; Enzymes; Female; General aspects; Genes; Genotype; Heart; Heart attacks; Humans; Logistic Models; Male; Medical sciences; Middle Aged; Myocardial Infarction - epidemiology; Myocardial Infarction - etiology; Myocardial Infarction - genetics; Myocarditis. Cardiomyopathies; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Risk Factors; Studies
• ISSN: 0098-7484; 1538-3598
• DOI: 10.1001/jama.295.10.1135

CONTEXT The association between coffee intake and risk of myocardial infarction (MI) remains controversial. Coffee is a major source of caffeine, which is metabolized by the polymorphic cytochrome P450 1A2 (CYP1A2) enzyme. Individuals who are homozygous for the CYP1A2*1A allele are “rapid” caffeine metabolizers, whereas carriers of the variant CYP1A2*1F are “slow” caffeine metabolizers. OBJECTIVE To determine whether CYP1A2 genotype modifies the association between coffee consumption and risk of acute nonfatal MI. DESIGN, SETTING, AND PARTICIPANTS Cases (n = 2014) with a first acute nonfatal MI and population-based controls (n = 2014) living in Costa Rica between 1994 and 2004, matched for age, sex, and area of residence, were genotyped by restriction fragment–length polymorphism polymerase chain reaction. A food frequency questionnaire was used to assess the intake of caffeinated coffee. MAIN OUTCOME MEASURE Relative risk of nonfatal MI associated with coffee intake, calculated using unconditional logistic regression. RESULTS Fifty-five percent of cases (n = 1114) and 54% of controls (n = 1082) were carriers of the slow *1F allele. For carriers of the slow *1F allele, the multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of nonfatal MI associated with consuming less than 1, 1, 2 to 3, and 4 or more cups of coffee per day were 1.00 (reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83), and 1.64 (1.14-2.34), respectively. Corresponding ORs (95% CIs) for individuals with the rapid *1A/*1A genotype were 1.00, 0.75 (0.51-1.12), 0.78 (0.56-1.09), and 0.99 (0.66-1.48) (P = .04 for gene × coffee interaction). For individuals younger than the median age of 59 years, the ORs (95% CIs) associated with consuming less than 1, 1, 2 to 3, or 4 or more cups of coffee per day were 1.00, 1.24 (0.71-2.18), 1.67 (1.08-2.60), and 2.33 (1.39-3.89), respectively, among carriers of the *1F allele. The corresponding ORs (95% CIs) for those with the *1A/*1A genotype were 1.00, 0.48 (0.26-0.87), 0.57 (0.35-0.95), and 0.83 (0.46-1.51). CONCLUSION Intake of coffee was associated with an increased risk of nonfatal MI only among individuals with slow caffeine metabolism, suggesting that caffeine plays a role in this association.